Cargando…

The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics

Smoking cessation represents an untapped resource for cancer therapy. Many people who smoke and have cancer (tobacco-related or otherwise) struggle to quit and as a result, jeopardise response to treatment, recovery after surgery and long-term survival. Many health care practitioners working in canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Emily, Paul, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497727/
https://www.ncbi.nlm.nih.gov/pubmed/36135066
http://dx.doi.org/10.3390/curroncol29090497
_version_ 1784794577710874624
author Stone, Emily
Paul, Christine
author_facet Stone, Emily
Paul, Christine
author_sort Stone, Emily
collection PubMed
description Smoking cessation represents an untapped resource for cancer therapy. Many people who smoke and have cancer (tobacco-related or otherwise) struggle to quit and as a result, jeopardise response to treatment, recovery after surgery and long-term survival. Many health care practitioners working in cancer medicine feel undertrained, unprepared and unsupported to provide effective smoking cessation therapy. Many institutions and healthcare systems do provide smoking cessation programs, guidelines and referral pathways for cancer patients, but these may be unevenly applied. The growing body of evidence, from both retrospective and prospective clinical studies, confirms the benefit of smoking cessation and will provide much needed evidence for the best and most effective interventions in cancer clinics. In addition to reducing demand, helping cancer patients quit and treating addiction, a firm commitment to developing smoke free societies may transform cancer medicine in the future. While the Framework Convention for Tobacco Control (FCTC) has dominated global tobacco control for the last two decades, many jurisdictions are starting to develop plans to make their communities tobacco free, to introduce the tobacco endgame. Characterised by downward pressure on tobacco supply, limited sales, limited access and denormalization of smoking, these policies may radically change the milieu in which people with cancer receive treatment, in which health care practitioners refine skills and which may ultimately foster dramatic improvements in cancer outcomes.
format Online
Article
Text
id pubmed-9497727
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94977272022-09-23 The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics Stone, Emily Paul, Christine Curr Oncol Review Smoking cessation represents an untapped resource for cancer therapy. Many people who smoke and have cancer (tobacco-related or otherwise) struggle to quit and as a result, jeopardise response to treatment, recovery after surgery and long-term survival. Many health care practitioners working in cancer medicine feel undertrained, unprepared and unsupported to provide effective smoking cessation therapy. Many institutions and healthcare systems do provide smoking cessation programs, guidelines and referral pathways for cancer patients, but these may be unevenly applied. The growing body of evidence, from both retrospective and prospective clinical studies, confirms the benefit of smoking cessation and will provide much needed evidence for the best and most effective interventions in cancer clinics. In addition to reducing demand, helping cancer patients quit and treating addiction, a firm commitment to developing smoke free societies may transform cancer medicine in the future. While the Framework Convention for Tobacco Control (FCTC) has dominated global tobacco control for the last two decades, many jurisdictions are starting to develop plans to make their communities tobacco free, to introduce the tobacco endgame. Characterised by downward pressure on tobacco supply, limited sales, limited access and denormalization of smoking, these policies may radically change the milieu in which people with cancer receive treatment, in which health care practitioners refine skills and which may ultimately foster dramatic improvements in cancer outcomes. MDPI 2022-09-01 /pmc/articles/PMC9497727/ /pubmed/36135066 http://dx.doi.org/10.3390/curroncol29090497 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Stone, Emily
Paul, Christine
The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics
title The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics
title_full The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics
title_fullStr The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics
title_full_unstemmed The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics
title_short The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics
title_sort tobacco endgame—a new paradigm for smoking cessation in cancer clinics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497727/
https://www.ncbi.nlm.nih.gov/pubmed/36135066
http://dx.doi.org/10.3390/curroncol29090497
work_keys_str_mv AT stoneemily thetobaccoendgameanewparadigmforsmokingcessationincancerclinics
AT paulchristine thetobaccoendgameanewparadigmforsmokingcessationincancerclinics
AT stoneemily tobaccoendgameanewparadigmforsmokingcessationincancerclinics
AT paulchristine tobaccoendgameanewparadigmforsmokingcessationincancerclinics